AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104. A total of 116 filers reported holding AUDENTES THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 1.14 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $6,616,000 | -24.9% | 235,552 | +1.2% | 0.00% | -20.0% |
| Q2 2019 | $8,809,000 | -44.5% | 232,686 | -42.0% | 0.01% | -37.5% |
| Q3 2018 | $15,880,000 | +5.2% | 401,100 | +1.5% | 0.01% | 0.0% |
| Q2 2018 | $15,101,000 | +44.4% | 395,200 | +13.5% | 0.01% | +60.0% |
| Q1 2018 | $10,460,000 | -3.8% | 348,100 | 0.0% | 0.01% | 0.0% |
| Q4 2017 | $10,878,000 | +5.8% | 348,100 | -5.2% | 0.01% | 0.0% |
| Q3 2017 | $10,282,000 | +46.4% | 367,100 | 0.0% | 0.01% | +25.0% |
| Q2 2017 | $7,023,000 | +12.3% | 367,100 | 0.0% | 0.00% | +33.3% |
| Q1 2017 | $6,255,000 | -6.7% | 367,100 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,707,000 | +2.6% | 367,100 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,538,000 | – | 367,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 294,013 | $11,131,000 | 9.27% |
| GREAT POINT PARTNERS LLC | 1,922,937 | $72,802,000,000 | 8.08% |
| Versant Venture Management, LLC | 553,916 | $20,971,260,000 | 6.11% |
| Foresite Capital Management III, LLC | 315,331 | $11,938,000 | 3.92% |
| Casdin Capital, LLC | 965,000 | $36,534,900,000 | 3.42% |
| Sofinnova Investments, Inc. | 933,640 | $35,348,000 | 3.25% |
| Opaleye Management Inc. | 280,000 | $10,601,000 | 3.23% |
| Redmile Group, LLC | 2,972,167 | $112,526,000 | 3.18% |
| PFM Health Sciences, LP | 3,228,679 | $122,238,000 | 2.32% |
| Eversept Partners, LP | 159,526 | $6,039,654 | 1.69% |